Case Report
Copyright ©2009 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Apr 14, 2009; 15(14): 1779-1781
Published online Apr 14, 2009. doi: 10.3748/wjg.15.1779
Successful treatment of multiple lung metastases of hepatocellular carcinoma by combined chemotherapy with docetaxel, cisplatin and tegafur/uracil
Atsunori Tsuchiya, Michitaka Imai, Hiroteru Kamimura, Tadayuki Togashi, Kouji Watanabe, Kei-ichi Seki, Toru Ishikawa, Hironobu Ohta, Toshiaki Yoshida, Tomoteru Kamimura
Atsunori Tsuchiya, Michitaka Imai, Hiroteru Kamimura, Kouji Watanabe, Kei-ichi Seki, Toru Ishikawa, Hironobu Ohta, Toshiaki Yoshida, Tomoteru Kamimura, Department of Gastroenterology, Saiseikai Niigata Second Hospital, Nishi-Ku, Teraji 280-7, Niigata 950-1104, Japan
Atsunori Tsuchiya, Hiroteru Kamimura, Tadayuki Togashi, Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Science, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan
Author contributions: Tsuchiya A, Imai M, and Togashi T performed research; Kamimura H, Watanabe K, Seki K, Ishikawa T, Ohta H, Yoshida T and Kamimura T designed research. Tsuchiya A wrote the paper.
Correspondence to: Atsunori Tsuchiya, Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Science, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata 951-8510, Japan. atsunori@med.niigata-u.ac.jp
Telephone: +81-25-2272207
Fax: +81-25-2270776
Received: December 23, 2008
Revised: March 2, 2009
Accepted: March 9, 2009
Published online: April 14, 2009
Abstract

We report the successful treatment of multiple lung metastases after hepatic resection for hepatocellular carcinoma (HCC) with combined docetaxel, cisplatin (CDDP), and enteric-coated tegafur/uracil (UFT-E). A 68-year-old man was diagnosed with multiple lung metastases of HCC 7 mo after partial hepatectomy for HCC. Oral UFT-E was given daily and docetaxel and CDDP were given intra-arterially (administered just before the bronchial arteries) every 2 wk via a subcutaneous injection port. One month after starting chemotherapy, levels of tumor marker, protein induced by vitamin K absence II (PIVKA-II), decreased rapidly, and after a further month, chest X-ray and computed tomography revealed the complete disappearance of multiple liver metastases. Two years after the combined chemotherapy, HCC recurred in the liver and was treated but no pulmonary recurrence occurred. In the absence of a standardized highly effective therapy, this combined chemotherapy with docetaxel, CDDP and UFT-E may be an attractive option for multiple lung metastases of HCC.

Keywords: Hepatocellular carcinoma, Docetaxel, Lung metastasis, Cisplatin